Ajanta Pharma (AJANTPHARM) — Announcement

📢 Key Event
Ajanta Pharma announces August 2026 investor meeting schedule

💡 Investor Takeaway
Investors can expect direct engagement with management during scheduled analyst meetings in August 2026.

Ajanta Pharma announced its schedule for analyst and institutional investor meetings in August 2026, including one-on-one sessions at the Nuvama India Conference in Singapore and Hong Kong and a meeting at Motilal's Global Conference in Mumbai. These events provide updated engagement opportunities with investors following recent regulatory filings.

📄 View Original Announcement (PDF)

📊 Stock Analysis — AJANTPHARM ✨ Ask AI About This

About Ajanta Pharma Limited (AJANTPHARM)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹44,226.59 Cr P/E: 39.0 ROE: 25.1% ROCE: 31.8% Div Yield: 0.79%

View full AJANTPHARM stock details →

📡 Get AI alerts when AJANTPHARM files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track AJANTPHARM — Free

💡 Ask AI about this filing

"When will the August 2026 investor meetings occur?" "What topics will be discussed at the Nuvama conference?" "How does this schedule impact Ajanta Pharma's stock outlook?"

Ask AI Free →

📊 More AJANTPHARM filings

See all AJANTPHARM filings →

🔥 Also filed on 5 August 2026

MAYURUNIQ Mayur Uniquoters Ltd Annual Report BEL Bharat Electronics Limited Corporate Action KIMS Krishna Institute of Medical Sciences Limited Annual Report RPTECH Rashi Peripherals Limited Financial Results RELINFRA Reliance Infrastructure Limited Announcement GREAVESCOT Greaves Cotton Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when AJANTPHARM files new disclosures

Track AJANTPHARM filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track AJANTPHARM — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd